NCT03244982View on ClinicalTrials.gov

Fluorescein Angiography With a Full-dose Versus a Half-dose of Intravenous Fluorescein

PHASE4SuspendedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

April 5, 2018

Primary Completion Date

July 17, 2019

Study Completion Date

December 1, 2020

Conditions
Fluorescein Angiography
Interventions
DRUG

Fluorescein Na 10% Inj 500mg

Full-dose intravenous Fluorescein Na prior to fluorescein angiography.

DRUG

Fluorescein Na 10% Inj 250mg

Half-dose intravenous Fluorescein Na prior to fluorescein angiography.

Trial Locations (1)

48201

Kresge Eye Institute, Detroit

Sponsors
All Listed Sponsors
lead

Kresge Eye Institute

OTHER